Calprotectin — A Marker of Mortality in COPD? Results from a Prospective Cohort Study

References

• Lash TL, Johansen MB, Christensen S, Baron JA, Rothman KJ, Hansen JG, Hospitalization rates and survival associated with COPD: a nationwide Danish cohort study. Lung 2011; 189(1):27–35. Epub 2010/12/21.
   PubMed Web of Science ®Google Scholar
• Pauwels RA, Rabe KF. Burden and clinical features of chronic obstructive pulmonary disease (COPD). Lancet 2004; 364(9434):613–620. Epub 2004/08/18.
   Google Scholar
• Lopez AD, Mathers CD, Ezzati M, Jamison DT, Murray CJ. Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data. Lancet 2006; 367(9524):1747–1757. Epub 2006/05/30.
   PubMed Web of Science ®Google Scholar
• Celli BR, MacNee W. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. The European respiratory journal : official journal of the European Soc Clin Respir Physiol 2004; 23(6):932–946. Epub 2004/06/29.
   PubMed Web of Science ®Google Scholar
• Stockley RA. Neutrophils and the pathogenesis of COPD. Chest 2002; 121(5 Suppl):151S–155S. Epub 2002/05/16.
   PubMed Web of Science ®Google Scholar
• Cornwell WD, Kim V, Song C, Rogers TJ. Pathogenesis of inflammation and repair in advanced COPD. Semin Respir Crit Care Med 2010; 31(3):257–266. Epub 2010/05/25.
   PubMed Web of Science ®Google Scholar
• Hogg JC, Chu F, Utokaparch S, Woods R, Elliott WM, Buzatu L, The nature of small-airway obstruction in chronic obstructive pulmonary disease. New Engl J Med 2004; 350(26):2645–2653. Epub 2004/06/25.
   PubMed Web of Science ®Google Scholar
• Moermans C, Heinen V, Nguyen M, Henket M, Sele J, Manise M, Local and systemic cellular inflammation and cytokine release in chronic obstructive pulmonary disease. Cytokine 2011; 56(2):298–304. Epub 2011/09/02.
   PubMed Web of Science ®Google Scholar
• Sinden NJ, Stockley RA. Systemic inflammation and comorbidity in COPD: A result of ‘overspill’ of inflammatory mediators from the lungs? Review of the evidence. Thorax 2010; 65(10):930–936. Epub 2010/07/16.
   PubMed Web of Science ®Google Scholar
• Quint JK, Wedzicha JA. The neutrophil in chronic obstructive pulmonary disease. J Allergy Clin Immunol 2007; 119(5):1065–1071. Epub 2007/02/03.
   PubMed Web of Science ®Google Scholar
• Donaldson GC, Seemungal TA, Bhowmik A, Wedzicha JA. Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease. Thorax. 2002; 57(10):847–52. Epub 2002/09/27.
   PubMed Web of Science ®Google Scholar
• Sethi S. Infectious etiology of acute exacerbations of chronic bronchitis. Chest 2000; 117(5 Suppl 2):380S–385S. Epub 2000/06/10.
   Web of Science ®Google Scholar
• Hurst JR, Donaldson GC, Perera WR, Wilkinson TM, Bilello JA, Hagan GW, Use of plasma biomarkers at exacerbation of chronic obstructive pulmonary disease. Amer J Respir Crit Care Med 2006; 174(8):867–874. Epub 2006/06/27.
   PubMed Web of Science ®Google Scholar
• Landbo C, Prescott E, Lange P, Vestbo J, Almdal TP. Prognostic value of nutritional status in chronic obstructive pulmonary disease. Amer J Respir Crit Care Med 1999; 160(6):1856–1861. Epub 1999/12/10.
   PubMed Web of Science ®Google Scholar
• Anthonisen NR, Wright EC, Hodgkin JE. Prognosis in chronic obstructive pulmonary disease. Amer Rev Respir Dis 1986; 133(1):14–20. Epub 1986/01/01.
   PubMed Web of Science ®Google Scholar
• Fan VS, Curtis JR, Tu SP, McDonell MB, Fihn SD. Using quality of life to predict hospitalization and mortality in patients with obstructive lung diseases. Chest 2002; 122(2):429–436. Epub 2002/08/13.
   PubMed Web of Science ®Google Scholar
• Nishimura K, Izumi T, Tsukino M, Oga T. Dyspnea is a better predictor of 5-year survival than airway obstruction in patients with COPD. Chest 2002; 121(5): 1434–1440. Epub 2002/05/15.
   PubMed Web of Science ®Google Scholar
• Celli BR, Cote CG, Marin JM, Casanova C, Montes de Oca M, Mendez RA, The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. New Engl J Med 2004; 350(10):1005–1012. Epub 2004/03/05.
   PubMed Web of Science ®Google Scholar
• Man SF, Connett JE, Anthonisen NR, Wise RA, Tashkin DP, Sin DD. C-reactive protein and mortality in mild to moderate chronic obstructive pulmonary disease. Thorax 2006; 61(10):849–53. Epub 2006/06/02.
   PubMed Web of Science ®Google Scholar
• Mannino DM, Valvi D, Mullerova H, Tal-Singer R. Fibrinogen, COPD and Mortality in a Nationally Representative U.S. Cohort. COPD August 2012; 9(4):359–366. Epub 2012/04/12.
   PubMedGoogle Scholar
• Sin DD, Miller BE, Duvoix A, Man SF, Zhang X, Silverman EK, Serum PARC/CCL-18 concentrations and health outcomes in chronic obstructive pulmonary disease. Amer J Respir Crit Care Med 2011; 183(9):1187–1192. Epub 2011/01/11.
   PubMed Web of Science ®Google Scholar
• Celli BR, Locantore N, Yates J, Tal-Singer R, Miller BE, Bakke P, Inflammatory biomarkers improve clinical prediction of mortality in chronic obstructive pulmonary disease. Amer J Respir Crit Care Med 2012; 185(10):1065–1072. Epub 2012/03/20.
   PubMed Web of Science ®Google Scholar
• de Torres JP, Pinto-Plata V, Casanova C, Mullerova H, Cordoba-Lanus E, Muros de Fuentes M, C-reactive protein levels and survival in patients with moderate to very severe COPD. Chest 2008; 133(6):1336–1343. Epub 2008/03/15.
   PubMed Web of Science ®Google Scholar
• Dickens JA, Miller BE, Edwards LD, Silverman EK, Lomas DA, Tal-Singer R. COPD association and repeatability of blood biomarkers in the ECLIPSE cohort. Respir Res 2011; 12(1):146. Epub 2011/11/08.
   PubMedGoogle Scholar
• Dentener MA, Creutzberg EC, Pennings HJ, Rijkers GT, Mercken E, Wouters EF. Effect of infliximab on local and systemic inflammation in chronic obstructive pulmonary disease: a pilot study. Respir Inter Rev thor Dis 2008; 76(3):275–282. Epub 2008/02/16.
   Google Scholar
• Striz I, Trebichavsky I. Calprotectin - a pleiotropic molecule in acute and chronic inflammation. Physiol Res/ Acad Scient Bohemoslovaca 2004; 53(3):245–253. Epub 2004/06/24.
   PubMed Web of Science ®Google Scholar
• Hsu K, Champaiboon C, Guenther BD, Sorenson BS, Khammanivong A, Ross KF, Anti-infective protective properties of S100 calgranulins. Anti-Inflam Anti-Allergy Agents Med Chem 2009; 8(4):290–305. Epub 2010/06/05.
   PubMedGoogle Scholar
• Edgeworth J, Gorman M, Bennett R, Freemont P, Hogg N. Identification of p8,14 as a highly abundant heterodimeric calcium binding protein complex of myeloid cells. J Biol Chem 1991; 266(12):7706–7713. Epub 1991/04/25.
   PubMed Web of Science ®Google Scholar
• Voganatsi A, Panyutich A, Miyasaki KT, Murthy RK. Mechanism of extracellular release of human neutrophil calprotectin complex. J Leuk Biol 2001; 70(1):130–134. Epub 2001/07/04.
   PubMed Web of Science ®Google Scholar
• Rammes A, Roth J, Goebeler M, Klempt M, Hartmann M, Sorg C. Myeloid-related protein (MRP) 8 and MRP14, calcium-binding proteins of the S100 family, are secreted by activated monocytes via a novel, tubulin-dependent pathway. J Biol Chem 1997; v272(14):9496–9502. Epub 1997/04/04.
   Google Scholar
• Vogl T, Tenbrock K, Ludwig S, Leukert N, Ehrhardt C, van Zoelen MA, Mrp8 and Mrp14 are endogenous activators of Toll-like receptor 4, promoting lethal, endotoxin-induced shock. Nat Med 2007; 13(9):1042–1049. Epub 2007/09/04.
   PubMed Web of Science ®Google Scholar
• Clohessy PA, Golden BE. Calprotectin-mediated zinc chelation as a biostatic mechanism in host defence. Scand J Immunol 1995; 42(5):551–6. Epub 1995/11/01.
   PubMed Web of Science ®Google Scholar
• Harrison CA, Raftery MJ, Walsh J, Alewood P, Iismaa SE, Thliveris S, Oxidation regulates the inflammatory properties of the murine S100 protein S100A8. J Biol Chem 1999; 274(13):8561–8569. Epub 1999/03/20.
   PubMed Web of Science ®Google Scholar
• Raftery MJ, Yang Z, Valenzuela SM, Geczy CL. Novel intra- and inter-molecular sulfinamide bonds in S100A8 produced by hypochlorite oxidation. J Biol Chem 2001; 276(36):33393–33401. Epub 2001/07/11.
   PubMed Web of Science ®Google Scholar
• Ryckman C, Vandal K, Rouleau P, Talbot M, Tessier PA. Proinflammatory activities of S100: proteins S100A8, S100A9, and S100A8/A9 induce neutrophil chemotaxis and adhesion. J Immunol 2003; 170(6):3233–3242. Epub 2003/03/11.
   PubMed Web of Science ®Google Scholar
• Sohnle PG, Collins-Lech C, Wiessner JH. The zinc-reversible antimicrobial activity of neutrophil lysates and abscess fluid supernatants. J Infect Dis 1991; 164(1):137–142. Epub 1991/07/01.
   PubMed Web of Science ®Google Scholar
• Sohnle PG, Collins-Lech C, Wiessner JH. Antimicrobial activity of an abundant calcium-binding protein in the cytoplasm of human neutrophils. J Infect Dis 1991; 163(1):187–192. Epub 1991/01/01.
   PubMed Web of Science ®Google Scholar
• Carroccio A, Rocco P, Rabitti PG, Di Prima L, Forte GB, Cefalu AB, Plasma calprotectin levels in patients suffering from acute pancreatitis. Digest Dis Sci 2006; 51(10):1749–1753. Epub 2006/09/12.
   PubMed Web of Science ®Google Scholar
• Pechkovsky DV, Zalutskaya OM, Ivanov GI, Misuno NI. Calprotectin (MRP8/14 protein complex) release during mycobacterial infection in vitro and in vivo. FEMS Immunol Med Microbiol 2000; 29(1):27–33. Epub 2000/09/01.
   PubMed Web of Science ®Google Scholar
• Manolakis AC, Kapsoritakis AN, Tiaka EK, Potamianos SP. Calprotectin, calgranulin C, and other members of the s100 protein family in inflammatory bowel disease. Digestive diseases and sciences. 2011; 56(6):1601–1611. Epub 2011/01/05.
   Google Scholar
• Andres Cerezo L, Mann H, Pecha O, Plestilova L, Pavelka K, Vencovsky J, Decreases in serum levels of S100A8/9 (calprotectin) correlate with improvements in total swollen joint count in patients with recent-onset rheumatoid arthritis. Arthr Res Ther 2011; 13(4): R122. Epub 2011/07/28.
   PubMed Web of Science ®Google Scholar
• Gray RD, MacGregor G, Noble D, Imrie M, Dewar M, Boyd AC, Sputum proteomics in inflammatory and suppurative respiratory diseases. Amer J Respir Crit Care Med 2008; 178(5):444–452. Epub 2008/06/21.
   PubMed Web of Science ®Google Scholar
• Raquil MA, Anceriz N, Rouleau P, Tessier PA. Blockade of antimicrobial proteins S100A8 and S100A9 inhibits phagocyte migration to the alveoli in streptococcal pneumonia. J Immunol 2008; 180(5):3366–3374. Epub 2008/02/23.
   PubMed Web of Science ®Google Scholar
• Gray RD, Imrie M, Boyd AC, Porteous D, Innes JA, Greening AP. Sputum and serum calprotectin are useful biomarkers during CF exacerbation. J Cyst Fibr Euro Cyst Fibr Soc 2010; 9(3):193–198. Epub 2010/03/20.
   PubMed Web of Science ®Google Scholar
• Dale I. Plasma levels of the calcium-binding L1 leukocyte protein: standardization of blood collection and evaluation of reference intervals in healthy controls. Scand J Clin Lab Invest 1990; 50(8):837–841. Epub 1990/12/01.
   PubMed Web of Science ®Google Scholar
• Mortensen OH, Nielsen AR, Erikstrup C, Plomgaard P, Fischer CP, Krogh-Madsen R, Calprotectin—A novel marker of obesity. PloS One 2009; 4(10): e7419. Epub 2009/10/14.
   Web of Science ®Google Scholar
• Nijhuis J, Rensen SS, Slaats Y, van Dielen FM, Buurman WA, Greve JW. Neutrophil activation in morbid obesity, chronic activation of acute inflammation. Obesity (Silver Spring) 2009; 17(11):2014–2018. Epub 2009/04/25.
   PubMed Web of Science ®Google Scholar
• Peduzzi P, Concato J, Feinstein AR, Holford TR. Importance of events per independent variable in proportional hazards regression analysis. II. Accuracy and precision of regression estimates. J Clinical Epidemiol 1995; 48(12):1503–1510. Epub 1995/12/01.
   PubMed Web of Science ®Google Scholar
• Dahl M, Vestbo J, Lange P, Bojesen SE, Tybjaerg-Hansen A, Nordestgaard BG. C-reactive protein as a predictor of prognosis in chronic obstructive pulmonary disease. Amer J Resp Crit Care Med 2007; 175(3):250–255. Epub 2006/10/21.
   PubMed Web of Science ®Google Scholar
• Ricanek P, Brackmann S, Perminow G, Lyckander LG, Sponheim J, Holme O, Evaluation of disease activity in IBD at the time of diagnosis by the use of clinical, biochemical, and fecal markers. Scand J Gastroenterol 2011; 46(9):1081–1091. Epub 2011/05/31.
   PubMed Web of Science ®Google Scholar
• Vestbo J, Rennard S. Chronic obstructive pulmonary disease biomarker(s) for disease activity needed—urgently. Amer J Respir Crit Care Med 2010; 182(7):863–864. Epub 2010/10/05.
   PubMed Web of Science ®Google Scholar